| Company | Round investors | Industry | Round value (USD) |
|---|---|---|---|
 TIRmed Pharma | Almi Invest | Health services, Pharma | 630k |
 Pharvaris | Bain Capital, Cormorant Asset Management, Foresite Capital, General Atlantic, venBio Partners, Venrock Healthcare Capital Partners, Viking Global Investors | Biotech, Health services, Pharma | 80M |
 Ability Pharma | Capital Cell | Health services, Manufacturing, Pharma | 2.37M |
 Myricx Pharma | Brandon Capital Partners, Sofinnova Partners | Health services, Pharma | 6.02M |
 Octarine Bio | Bruce Linton, Enexis AB, Oskare Capital, Vækstfonden | Biotech, Health services, Manufacturing, Pharma | 1.8M |
| Name | Industries | Date | Round value (USD) |
|---|---|---|---|
| Octarine Bio | Biotech, Health services, Manufacturing, Pharma | Nov 2020 | 1.8M |
| TIRmed Pharma | Health services, Pharma | Nov 2020 | 630k |
| Investor | Type | Average inv. round (USD) | Transactions |
|---|---|---|---|
| Enexis AB | Venture Capital | 1.8M | 1 |
| Vækstfonden | Venture Capital | 1.8M | 1 |
| Almi Invest | Others | 630k | 1 |
| Name | Industries | Value of transactions | Transactions |
|---|---|---|---|
| Stockholm | Health services (1), Pharma (1) | 630k | 1 |
| Copenhagen | Manufacturing (1), Biotech (1), Health services (1) | 1.8M | 1 |